Mucinous Differentiation in Colorectal Cancer: Molecular, Histological and Clinical Aspects

References

• HEINZELMANN-SCHWARZ V. A., GARDINER-GARDEN M., Henshall S. M., Scurry J. P., Scolyer R. A., Smith A. N., Bali A., Vanden Bergh P., Baron-Hay S., Scott c., Fink d., Hacker N. F., Sutherland K. L., O’Brien P. M. A distinct molecular profile associated with mucinous epithelial ovarian cancer. British Journal of Cancer, 2006, 94: 904–913.
   Google Scholar
• Langner C., Harbaum L., Pollheimer M. J., Kornprat P., Lindtner K. A., Schlemmer A., Vieth M., Rehak P. Mucinous differentiation in colorectal cancer - indicator of poor prognosis ? Histopathology, 2012, 60: 1060–1072.
   Google Scholar
• Xie L., Villeneuve P. J., Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcino-ma: A population-based study in Canada. International Journal of Oncology, 2009, 34: 1109–1115.
   Google Scholar
• Snover D. C. Update on the serrated pathway to colorectal carcinoma. Hum Pathol, 2011, 42: 1–10.
   Google Scholar
• Mekenkamp L. J. M., Heesterbeek K. J., Koopman M., Tol J., Teerenstra S., Venderbosch S., Punt C. J. A., Nagtegaal I. D. Mucinous adenocarcinomas: Poor prognosis in metastatic colo-rectal cancer. European Journal of Cancer, 2012, 48: 501–509.
   Google Scholar
• Numata M., Shiozawa M., Watanabe T., Tamagawa H., Yamamoto N., Morinaga S., Watanabe K., Godai T., Oshima T., Fujii S., Kunisaki C., Rino Y., Masuda M., Akaike M. The clinico-pathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World Journal of Surgical Oncology, 2012, 10.
   Google Scholar
• Lam A. K. Y., Ong K., Ho Y. H. Colorectal mucinous adenocarcinoma: The clinicopathologic features and significance of p16 and p53 expression. Diseases of the Colon & Rectum, 2006, 49(9): 1275–1283.
   Google Scholar
• Nozoe T., Anai H., Nasu S., Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. Journal of Surgical Oncology, 2000, 75: 103–107.
   Google Scholar
• Ishihara S., Watanabe T., Akahane T., Shimada R., Horiuchi A., Shibuya H., Hayama T., Yamada H., Nozawa K., Matsuda K., Maeda K., Sugihara K. Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. International Journal of Colorectal Disease, 2012, 27: 371–379.
   Google Scholar
• Kanemitsu Y., Kato T., Hirai T., Yasui K., Morimoto T., SHiMizu Y., Kodera Y., Yamamura Y. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Diseases of the Colon & Rectum, 2003, 46: 160–167.
   Google Scholar
• Yamamoto S., Mochizuki H., Hase K., Yamamoto T., Ohkusa Y., Yokoyama S., ÜSHITANI Y., Tamakuma S. Assessment of clinico-pathological features of colorectal mucinous adenocarcinoma. American Journal of Surgery, 1993, 166: 257–261.
   Google Scholar
• Negri F. V., Wotherspoon A., cunningham D., Norman A. R., chong G., Ross P. J. Mucinous histology predicts for reduced fluo-rouracil responsiveness and survival in advanced colorectal cancer. Annals of Oncology, 2005, 16: 1305–1310.
   Google Scholar
• Park S. Y., Lee H. S., choe G., chung J. H., Kim W. H. Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adeno-carcinomas in relation to location. Virchows Archiv, 2006, 449: 40–47.
   Google Scholar
• Choi S. B., Lee I. K., Won D. Y., Lee Y. S., Si Y., Lee S. C., Kang W. K., Park J. K., Ahn c. H., Kim J. G., Oh S. T. Analysis of Prognosis in Colorectal Mucinous Adenocarcinoma: A Retrospective Analysis with Peritoneal Fluid. Journal of the Korean Surgical Society, 2010, 79: 474–480.
   Google Scholar
• Melis M., Hernandez J., Siegel E. M., McLoughlin J. M., Ly Q. P., Nair R. M., Lewis J. M., Jensen E. H., Alvarado M. D., coppola D., Eschrich S., Bloom G. c., Yeatman T. J., Shibata D. Gene Expression Profiling of Colorectal Mucinous Adenocarcino-mas. Diseases of the Colon & Rectum, 2010, 53: 936–943.
   Google Scholar
• Leopoldo S., Lorena B., cinzia A., Gabriella D. c., Luciana B. A., Renato c., Antonio M., carlo S., cristina P., Stefano c., Maurizio T., Luigi R., cesare B. Two subtypes of mucinous ade-nocarcinoma of the colorectum: Clinicopathological and genetic features. Annals of Surgical Oncology, 2008, 15: 1429–1439.
   Google Scholar
• Consorti F., Lorenzotti A., Midiri G., Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: A prospective case-control study. J Surg Oncol, 2000, 73: 70–74.
   Google Scholar
• catalano V., Loupakis F., Graziano F., Torresi u., Bisonni R., Mari D., Fornaro L., Baldelli A. M., Giordani P., Rossi D., Alessandroni P., Giustini L., Silva R. R., Falcone A., D’Emidio S., Fedeli S. L. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin-and/or irinotecan-based chemotherapy. British Journal of Cancer, 2009, 100: 881–887.
   Google Scholar
• catalano V., Loupakis F., Graziano F., Bisonni R., Torresi u., Vincenzi B., Mari D., Giordani P., Alessandroni P., Salvatore L., Fornaro L., Santini D., Baldelli A. M., Rossi D., Giustini L., Silva R. R., Falcone A., D’Emidio S., Rocchi M., Fedeli S. L. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Annals of Oncology, 2012, 23: 135-U111.
   Google Scholar
• chiang J. M., Yeh c. Y., changchien c. R., chen J. S., Tang R., chen J. R. Mucinous adenocarcinoma showing different clinico-pathological and molecular characteristics in relation to different colorectal cancer subgroups. International Journal of Colorectal Disease, 2010, 25: 941–947.
   Google Scholar
• Goi T., Obata S., Inoue T., Fujioka M., Hirono Y., Katayama K., Yamaguchi A. Clinicopathological study of the colorectal muci-nous carcinomas. International Surgery, 2006, 91: 352–357.
   Google Scholar
• Enriquez JM., Diez M., Tobaruela E., Lozano O., Dominguez P., Gonzalez A., Muguerza JM., Ratia T. Clinical, histopathological, cytogenetic and prognostic differences between mucinous and nonmucinous colorectal adenocarcinomas. Rev Esp Enferm Dig, 1998, 90: 568–572.
   Google Scholar
• Verhulst J., Ferdinande L., Demetter P., ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. Journal of Clinical Pathology, 2012, 65: 381–388.
   Google Scholar
• Kim T. H., Kim D. Y., Cho K. H., Kim Y. H., Jung K. H., Ahn J. B., chang H. J., Kim J. Y., choi H. S., Lim S. B., Sohn D. K., Jeong S. Y. Comparative analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients. Strahlenther Onkol, 2005, 181: 601–605.
   Google Scholar
• Glasgow S. c., Yu J., carvalho L. P., Shannon W. D., Fleshman J. W., McLeod H. L. Unfavourable expression of phar-macologic markers in mucinous colorectal cancer. British Journal of Cancer, 2005, 92: 259–264.
   Google Scholar
• Ikeda S., Shimizu Y., Fujimori M., Ishizaki Y., Kurihara T., Ojima Y., Okajima M., Asahara T. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Clinical Cancer Research, 2003, 9: 5660–5665.
   Google Scholar
• Tanaka H., Deng G. R., Matsuzaki K., Kakar S., Kim G. E., Miura S., Sleisenger M. H., Kim Y. S. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int J Cancer, 2006, 118: 2765–2771.
   Google Scholar
• Gemignani M. L., Schlaerth A. c., Bogomolniy F., Barakat R. R., Lin O., Soslow R., Venkatraman E., Boyd J. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecologic Oncology, 2003, 90: 378–381.
   Google Scholar
• Pai R. K., Jayachandran P., Koong A. c., chang D. T., Kwok S., Ma L., Arber D. A., Balise R. R., Tubbs R. R., Shadrach B. BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features. American Journal of Surgical Pathology, 2012, 36: 744752.
   Google Scholar
• Yoshitake N., Fujii S., Mukawa K., Tominaga K., Fukui H., Ichikawa K., Tomita S., Ono Y., Imai Y., Terano A., Hiraishi H., Fujimori T. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration. Oncology Reports, 2007, 17: 9–15.
   Google Scholar
• Hanski c., Hofmeier M., SchmittGraff A., Riede E., Hanski M. L., Borchard F., Sieber E., Niedobitek F., Foss H. D., Stein H., Riecken E. O. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. Journal of Pathology, 1997, 182: 385–391.
   Google Scholar
• Chou Y. Y., Jeng Y. M., Kao H. L., Chen T. J., Mao T. L., Lin M. c. Differentiation of ovarian mucinous carcinoma and met-astatic colorectal adenocarcinoma by immunostaining with beta-catenin. Histopathology, 2003, 43: 151–156.
   Google Scholar
• Losi L., ScARSELLi A., Benatti P., PoNz de Leon M., RoNcucci L., Pedroni M., Borghi F., Lamberti i., Rossi G., Marino M., Ponti G., Zangardi G., Menigatti M., Di Gregorio c. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. Pathol Res Pract, 2004, 200: 371–377.
   Google Scholar
• Messerini L., Vitelli F., DeVitis L. R., Mori s., calzolari A., Palmirotta R., calabro A., Papi L. Microsatellite instability in sporadic mucinous colorectal carcinomas: Relationship to clinico-pathological variables. J Pathol, 1997, 182: 380–384.
   Google Scholar
• Messerini L., ciantelli M., Baglioni s., Palomba A., Zampi G., Papi L. Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers. Human Pathology, 1999, 30: 629–634.
   Google Scholar
• Song G. A., Deng G. R., Bell i., Kakar s., sleisenger M. H., Kim Y. s. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. International Journal of Oncology, 2005, 26: 745–750.
   Google Scholar
• ügino s., Brahmandam M., cantor M., Namgyal c., Kawasaki T., Kirkner G., Meyerhardt J. A., Loda M., Fuchs cs. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Modern Pathology, 2006, 19: 59–68.
   Google Scholar
• Zhang H., Evertssün s., sun X. F. Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. Int J Oncol, 1999, 14: 1057–1061.
   Google Scholar
• Perez R. O., Bresciani B. H., Bresciani c., Proscurshim i., Kiss D., Gama-Rodrigues J., Pereira D. D., Rawet V., cecconnello i., Habr-Gama A. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. International Journal of Colorectal Disease, 2008, 23: 757–765.
   Google Scholar
• Niv Y. MUC1 and colorectal cancer pathophysiology considerations. World J Gastroenterol, 2008, 14: 2139–2141.
   Google Scholar
• Baldus s. E., Monig s. P., Huxel s., Landsberg s., Hanisch F. G., Engelmann K., schneider P. M., Thiele J., Holscher A. H., Dienes H. P. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res, 2004, 10: 2790–2796.
   Google Scholar
• Byrd J. c., Bresalier R. s. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev, 2004, 23: 77–99.
   Google Scholar
• Melis M., Hernandez J., siegel E. M., McLoughlin J. M., Ly Q. P., Nair R. M., Lewis J. M., Jensen E. H., Alvarado M. D., coppola D., Eschrich s., Bloom G. c., Yeatman T. J., shibata D. Gene expression profiling of colorectal mucinous adenocarcinomas. Dis Colon Rectum, 2010, 53: 936–943.
   Google Scholar
• Tozawa E., Ajioka Y., Watanabe H., Nishikura K., Mukai G., suda T., Kanoh T., Hatakeyama K. Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: Is mucinous carcinoma a distinct histological entity ? Pathology Research and Practice, 2007, 203: 567–574.
   Google Scholar
• Ishizu H., Kuniagai J., Eishi Y., Takizawa T., Koike M. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia. Journal of Gastroenterology, 2004, 39: 125–132.
   Google Scholar
• Losi L., scarselli A., Benatti P., de Leon M. P., RoNcucci L., Pedroni M., Borghi F., Lamberti I., Rossi G., Marino M., Ponti G., Zangardi G., Menigatti M., Di Gregorio c. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. Pathology Research and Practice, 2004, 200: 371–377.
   Google Scholar
• HiAVONE M. B., Herzog T. J., Lewin s. N., Deutsch I., sun X. M., Burke W. M., Wright J. D. Natural history and outcome of muci-nous carcinoma of the ovary. American Journal of Obstetrics and Gynecology, 2011, 205.
   Google Scholar
• wang L., Ma J., Liu F. H., Yu Q. K., chu G. M., Perkins A. c., Li Y. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Gynecologic Oncology, 2007, 105: 695–702.
   Google Scholar
• Danielczyk A., stahn R., Faulstich D., Loffler A., Marten A., Karsten u., Goletz s. PankoMab: a potent new generation anti-tumour MUC1 antibody. Cancer Immunol Immunother, 2006, 55: 1337–1347.
   Google Scholar
• Muller s., Hanisch F. G. Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glyco-sylation. J Biol Chem, 2002, 277: 26103–26112.
   Google Scholar
• Foon K. A., Yannelli J., Bhattacharya-chatterjee M. Colorectal cancer as a model for immunotherapy. Clin Cancer Res, 1999, 5: 225–236.
   Google Scholar